Zacks ranks Tenet Healthcare, NESR and Centene as strong buy growth stocks
Zacks Investment Research has assigned #1 (Strong Buy) ratings to Tenet Healthcare, National Energy Services Reunited, and Centene. The ratings are based on earnings growth and valuation metrics.
- Headline: Zacks ranks Tenet Healthcare, NESR and Centene as strong buy growth stocks
- Dispatch Summary: Zacks Investment Research has assigned #1 (Strong Buy) ratings to Tenet Healthcare, National Energy Services Reunited, and Centene. The ratings are based on earnings growth and valuation metrics.
- Verification: Corroborated across independent reporting outlets with primary sources and real-time wire transmissions.
Zacks Investment Research has highlighted three stocks—Tenet Healthcare, National Energy Services Reunited (NESR), and Centene—as top recommendations for investors seeking growth opportunities. These companies received a #1 (Strong Buy) rating, reflecting their strong earnings momentum and favorable valuation metrics. The analysis, published on finance.yahoo.com, underscores their potential to outperform the broader market.
Zacks Ranks Three Healthcare and Energy Stocks as Strong Buys
The Zacks Rank system evaluates stocks based on earnings revisions, valuation, and momentum. Tenet Healthcare, a diversified healthcare services company, has seen a 20.2% increase in its 2026 earnings estimate over the past 60 days. Its PEG ratio of 1.01 is slightly below the industry average of 1.07, suggesting it may be undervalued relative to its growth prospects. The company also holds a B-grade Growth Score, indicating strong fundamentals.
National Energy Services Reunited, an oilfield services firm, has a 4.6% rise in its earnings estimate and a PEG ratio of 0.31, significantly lower than the industry’s 0.55. This suggests the stock may be trading at a discount to its earnings potential. NESR’s A-grade Growth Score further supports its appeal to growth-oriented investors.
Centene, a managed care company, leads the trio with a 40.9% surge in its 2026 earnings estimate. Its PEG ratio of 0.44, well below the industry’s 1.49, highlights its attractive valuation. The company’s A-grade Growth Score reinforces its position as a high-potential investment.
| Stock | Zacks Rank | Earnings Estimate Growth (60 Days) | PEG Ratio | Industry PEG Average | Growth Score |
|---|---|---|---|---|---|
| Tenet Healthcare (THC) | #1 (Strong Buy) | 20.2% | 1.01 | 1.07 | B |
| National Energy Services Reunited (NESR) | #1 (Strong Buy) | 4.6% | 0.31 | 0.55 | A |
| Centene (CNC) | #1 (Strong Buy) | 40.9% | 0.44 | 1.49 | A |
Broader Market Context and Divergent Recommendations
While Zacks focuses on growth metrics, other outlets highlight different investment opportunities. For instance, The Times of India cited Aegis Logistics, Aarti Pharmalabs, and Just Dial as top recommendations for September 17, 2026, based on technical analysis. Meanwhile, Australian markets saw strong performances from ASX-listed gold stocks like Auric Mining and Solstice Minerals, which have surged in value due to rising commodity prices.
On the Canadian front, TC Energy (TRP) faced scrutiny after a 15% drop in its share price, with analysts debating whether the decline presents a buying opportunity. The stock’s recent struggles reflect broader concerns about rising interest rates and their impact on energy infrastructure companies.
MarketSmith India, as reported by livemint.com, noted a cautious outlook for the Nifty 50 index, which closed slightly higher but remained below key technical levels. The index’s weak breadth and elevated crude oil prices added to investor uncertainty, even as financial stocks like SBI and Axis Bank showed resilience.
Other Analysts’ Perspectives on Growth and Value Stocks
Several outlets emphasized the importance of diversification in portfolio strategies. For example, fool.com.au highlighted two under-the-radar ASX gold stocks, while fool.ca provided an in-depth analysis of TC Energy’s long-term dividend potential despite short-term volatility. These recommendations reflect varying approaches to risk and growth, with some analysts prioritizing immediate momentum and others focusing on long-term fundamentals.
In India, Nuvama Professional Clients Group’s recommendations for Aegis Logistics, Aarti Pharmalabs, and Just Dial centered on technical indicators such as moving averages and volume patterns. The firm’s analysis suggested that these stocks could benefit from broader market stabilization, though it cautioned against overexposure to volatile sectors.
Frequently Asked Questions
Why are Tenet Healthcare, NESR, and Centene ranked as strong buys by Zacks?
Zacks assigns the #1 rating based on strong earnings growth, favorable valuation metrics, and positive momentum. For example, Centene’s 40.9% increase in earnings estimates and low PEG ratio of 0.44 make it a compelling choice.
What is the significance of the PEG ratio in evaluating these stocks?
The PEG ratio (Price/Earnings to Growth ratio) compares a stock’s valuation to its earnings growth. A lower PEG ratio, such as NESR’s 0.31, suggests the stock may be undervalued relative to its growth potential compared to industry peers.
How do these stocks compare to their industry averages?
All three stocks have PEG ratios below their respective industry averages, indicating potential undervaluation. For instance, Centene’s PEG ratio of 0.44 is significantly lower than the industry’s 1.49.
The upcoming U.S. Federal Reserve decision, mentioned in livemint.com’s analysis, could serve as a key catalyst for market movements. Investors are likely to monitor this event closely, as it may influence interest rates, liquidity, and sector-specific performance. Meanwhile, the Zacks-recommended stocks remain a focal point for those seeking growth-oriented opportunities amid a mixed market landscape.
How significant is this wire dispatch?
Cast your anonymous vote to register reader consensus across journalism and intelligence sectors.
Dateline Wire is dedicated to independent, evidence-backed reporting. This briefing was synthesized from primary source reporting, corroborated across independent newsrooms, and verified against our Editorial Standards.